Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Eclinicalmedicine
|
July 1, 2021
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
Michael A Puskarich, Nathan W Cummins, Nicholas E Ingraham, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post Chemotherapy
Boris J N Winterhoff, Nomeda Girnius, Muyi Liu, et al.
The Journal of Pathology
|
May 15, 2023
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients
Sarah E Tarullo, Yuyu He, Claire Daughters, et al.
Nature Materials
|
December 1, 2020
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
Ori Maller, Allison P Drain, Alexander S Barrett, et al.
Nature Aging
|
July 3, 2023
Spatial mapping of cellular senescence: emerging challenges and opportunities
Aditi U Gurkar, Akos A Gerencser, Ana L Mora, et al.
Cell
|
August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Nature Genetics
|
September 15, 2025
Advancing biological understanding of cellular senescence with computational multiomics
Sheng Li, Paula A Agudelo Garcia, Constantin Aliferis, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Eclinicalmedicine
|
July 1, 2021
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
Michael A Puskarich, Nathan W Cummins, Nicholas E Ingraham, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post Chemotherapy
Boris J N Winterhoff, Nomeda Girnius, Muyi Liu, et al.
The Journal of Pathology
|
May 15, 2023
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients
Sarah E Tarullo, Yuyu He, Claire Daughters, et al.
Nature Materials
|
December 1, 2020
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
Ori Maller, Allison P Drain, Alexander S Barrett, et al.
Nature Aging
|
July 3, 2023
Spatial mapping of cellular senescence: emerging challenges and opportunities
Aditi U Gurkar, Akos A Gerencser, Ana L Mora, et al.
Cell
|
August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Nature Genetics
|
September 15, 2025
Advancing biological understanding of cellular senescence with computational multiomics
Sheng Li, Paula A Agudelo Garcia, Constantin Aliferis, et al.
Page
of 9